Knockdown of circ-PRKCH alleviates IL-1β-treated chondrocyte cell phenotypic changes through modulating

Zhongxing Liu1, Jian Cao1, Limin Zhang1

  • 1Department of Orthopedics, Affiliated Hospital of Chifeng University, Institute of Orthopaedic Diseases, Affiliated Hospital of Chifeng University, Chifeng, China.

Autoimmunity
|March 30, 2022
PubMed
Abstract

Insights

Circular RNA protein kinase C eta (circ-PRKCH) exacerbates osteoarthritis by sponging miR-502-5p and upregulating ADAMTS5. This circRNA may serve as a therapeutic target for osteoarthritis, offering a novel approach to cartilage degradation treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease.
  • Circular RNAs (circRNAs) play a role in OA pathogenesis.
  • The specific role of circRNA protein kinase C eta (circ-PRKCH) in OA requires further investigation.

Purpose of the Study:

  • To investigate the role and mechanism of circ-PRKCH in osteoarthritis.
  • To explore the regulatory relationship between circ-PRKCH, miR-502-5p, and ADAMTS5 in OA.
  • To assess the potential of circ-PRKCH as a biomarker for OA treatment.

Main Methods:

  • Quantitative real-time PCR and Western blot were used to measure gene and protein expression.
  • Dual-luciferase reporter and RNA Immunoprecipitation (RIP) assays verified molecular interactions.
  • Cellular assays (CCK-8, EDU, flow cytometry, ELISA) assessed chondrocyte function.
  • Exosome identification was performed using TEM and Western blot.

Main Results:

  • Circ-PRKCH and ADAMTS5 were upregulated, while miR-502-5p was downregulated in OA cartilage and chondrocytes.
  • Circ-PRKCH depletion improved chondrocyte viability, proliferation, and migration while reducing apoptosis and inflammation.
  • Circ-PRKCH acts as a sponge for miR-502-5p, regulating ADAMTS5 expression.
  • Exosomes from OA chondrocytes can transfer circ-PRKCH.

Conclusions:

  • Circ-PRKCH promotes OA progression by modulating the miR-502-5p/ADAMTS5 pathway in chondrocytes.
  • Circ-PRKCH may serve as a potential therapeutic target and biomarker for osteoarthritis.